Aldawaa Medical Services Co. posted a net profit of SAR 305.4 million in 2022, a 28% increase from SAR 239.2 million a year earlier.
Item | 2021 | 2022 | Change |
---|---|---|---|
Revenues | 5,034.38 | 5,372.24 | 6.7 % |
Gross Income | 1,894.40 | 2,019.60 | 6.6 % |
Operating Income | 267.89 | 374.35 | 39.7 % |
Net Income | 239.15 | 305.45 | 27.7 % |
Average Shares | 85.00 | 85.00 | - |
EPS (Riyals) | 2.81 | 3.59 | 27.7 % |
The profit jump was driven by a 6.7% year-on-year (YoY) leap in revenue to SAR 337.9 million, buoyed by higher cash, online and insurance sales. This is along with an uptick in sales from the Wasfaty e-prescribing program.
Gross profit climbed from SAR 1.89 billion in 2021 to SAR 2.01 billion in 2022, with a profit margin of 37.6%. Further, operating profit grew by SAR 101.1 million, or 37.7% YoY, to SAR 369 million last year.
The fourth-quarter net profit rose 30% YoY to SAR 89.51 million from SAR 69.08 million a year earlier.
Sequentially, net profit rose 85.9% from SAR 48.15 million in Q3 2022.
Item | Q4 2021 | Q4 2022 | Change |
---|---|---|---|
Revenues | 1,298.34 | 1,458.30 | 12.3 % |
Gross Income | 533.08 | 533.69 | 0.1 % |
Operating Income | 75.82 | 130.39 | 72.0 % |
Net Income | 69.08 | 89.51 | 29.6 % |
Average Shares | 85.00 | 85.00 | - |
EPS (Riyals) | 0.81 | 1.05 | 29.6 % |
Shareholders’ equity, no minority interest, stood at SAR 1.09 billion as of Dec. 31, 2022, compared to SAR 989.18 million a year earlier.
Period | Revenues | Change | Gross Income | Change | Operating Income | Change |
---|---|---|---|---|---|---|
Q1 2022 | 1,294.82 | 7.0 % | 494.18 | 9.3 % | 70.71 | (4.9 %) |
Q2 2022 | 1,310.19 | 3.4 % | 506.79 | 10.7 % | 90.55 | 35.3 % |
Q3 2022 | 1,308.93 | 3.9 % | 484.94 | 7.4 % | 82.69 | 62.7 % |
Q4 2022 | 1,458.30 | 12.3 % | 533.69 | 0.1 % | 130.39 | 72.0 % |
2022 | 5,372.24 | 6.7 % | 2,019.60 | 6.6 % | 374.35 | 39.7 % |
Period | Net Income | Change | EPS(Riyal) | Extraordinary Income/Expense | Net Profit Before Unusual Items | EPS Before XO Items |
---|---|---|---|---|---|---|
Q1 2022 | 87.11 | 10.5 % | 1.02 | 38.14 | 48.97 | 0.58 |
Q2 2022 | 80.67 | 52.4 % | 0.95 | 14.47 | 66.21 | 0.78 |
Q3 2022 | 48.15 | 25.7 % | 0.57 | (1.08) | 49.24 | 0.58 |
Q4 2022 | 89.51 | 29.6 % | 1.05 | 7.74 | 81.77 | 0.96 |
2022 | 305.45 | 27.7 % | 3.59 | 59.27 | 246.18 | 2.90 |
Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
---|---|---|---|
Q1 2022 | 37.83 % | 12.05 % | 3.27 % |
Q2 2022 | 38.46 % | 12.59 % | 3.61 % |
Q3 2022 | 38.74 % | 13.20 % | 3.98 % |
Q4 2022 | 37.59 % | 13.57 % | 4.58 % |
2022 | 37.59 % | 13.57 % | 4.58 % |
Period | Shares Outstanding (M) | EPS (Riyal) | Adjusted EPS (Riyal) | Book Value (BV) |
---|---|---|---|---|
Q1 2022 | 85.00 | 2.91 | 1.97 | 12.61 |
Q2 2022 | 85.00 | 3.24 | 2.19 | 12.78 |
Q3 2022 | 85.00 | 3.35 | 2.44 | 12.07 |
Q4 2022 | 85.00 | 3.59 | 2.90 | 12.88 |
Period | P/E | Adjusted P/E | Price/book |
---|---|---|---|
Q1 2022 | 25.59 | 37.84 | 5.91 |
Q2 2022 | 20.70 | 30.54 | 5.24 |
Q3 2022 | 23.77 | 32.69 | 6.61 |
Q4 2022 | 20.01 | 24.83 | 5.58 |
Q4 2022
Period | Retail Sales | Wholesale |
---|---|---|
Q1 2022 | 1,260.57 | 34.25 |
Q2 2022 | 1,268.35 | 41.84 |
Q3 2022 | 1,261.85 | 47.08 |
Q4 2022 | 1,376.54 | 81.76 |
Current | |
Market Cap (M Riyal) | 6,808.50 |
Enterprise Value (EV) (M) | 7,366.97 |
Shares Outstanding ((M)) | 85.00 |
EPS ( Riyal) (TTM) | 4.22 |
Book Value (BV) ( Riyal) | 16.65 |
Par Value ( Riyal) | 10.00 |
Adjusted P/E (Last12) | 18.98 |
P/E (TTM) | 18.98 |
Price/book | 4.81 |
Return on Average Assets (%) (TTM) | 7.5 |
Return on Average Equity (%) (TTM) | 27.4 |
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}